Why the study?
Does Epstein-Barr virus infection increase the risk of developing multiple sclerosis?
Does Epstein-Barr virus infection increase the risk of developing multiple sclerosis?
Current epidemiological evidence is insufficient to confirm or refute an etiological role of Epstein-Barr virus in multiple sclerosis.
Insufficient evidence precludes EBV-targeted MS prevention; leaves open causal hypothesis for larger prospective cohorts.
OBJECTIVE: To evaluate the epidemiological evidence for an etiological role of Epstein-Barr virus in multiple sclerosis (MS). DATA SOURCES: MEDLINE and Cochrane Library searches of the medical literature identified 24 studies. DATA EXTRACTION: Studies were categorized as seroepidemiological, case-control or historical cohort, and were then classified within each group according to methodological rigour using criteria derived from published guidelines for the epidemiological study of MS. DATA SYNTHESIS: There was significant variability in the quality of evidence, and while two well-designed cohort studies found increased relative risks of MS in subjects with infectious mononucleosis, results from other studies were unconvincing. CONCLUSIONS: The evidence was insufficient to accept or reject the hypothesis that Epstein-Barr virus has an etiological role in MS. Further study, ideally using large samples of incident cases with blinded, trained interviewers using confirmatory sources for recalled data, is needed.
No takes yet. Share an insight, caveat, or question.
Marrie et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: